These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 19015602
1. Candesartan and insulin reduce renal sympathetic nerve activity in hypertensive type 1 diabetic rats. Takimoto C, Kumagai H, Osaka M, Sakata K, Onami T, Kamayachi T, Iigaya K, Hayashi K, Saruta T, Itoh H. Hypertens Res; 2008 Oct; 31(10):1941-51. PubMed ID: 19015602 [Abstract] [Full Text] [Related]
2. Potentiated sympathetic nervous and renin-angiotensin systems reduce nonlinear correlation between sympathetic activity and blood pressure in conscious spontaneously hypertensive rats. Sakata K, Kumagai H, Osaka M, Onami T, Matsuura T, Imai M, Saruta T. Circulation; 2002 Jul 30; 106(5):620-5. PubMed ID: 12147546 [Abstract] [Full Text] [Related]
3. Role of AT1 receptors in permeability of the blood-brain barrier in diabetic hypertensive rats. Awad AS. Vascul Pharmacol; 2006 Sep 30; 45(3):141-7. PubMed ID: 16959546 [Abstract] [Full Text] [Related]
4. [Effects of angiotensin II receptor antagonist on insulin sensitivity and sympathetic activity in spontaneously hypertensive rats]. Sasaki K, Kushiro T, Nakagawa S, Kanmatsuse K. Nihon Jinzo Gakkai Shi; 1999 Oct 30; 41(7):692-6. PubMed ID: 10572394 [Abstract] [Full Text] [Related]
5. Roles of central renin-angiotensin system and afferent renal nerve in the control of systemic hemodynamics in rats. Fujisawa Y, Nagai Y, Lei B, Nakano D, Fukui T, Hitomi H, Mori H, Masaki T, Nishiyama A. Hypertens Res; 2011 Nov 30; 34(11):1228-32. PubMed ID: 21796126 [Abstract] [Full Text] [Related]
6. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats. Chung S, Park CW, Shin SJ, Lim JH, Chung HW, Youn DY, Kim HW, Kim BS, Lee JH, Kim GH, Chang YS. Nephrol Dial Transplant; 2010 Feb 30; 25(2):389-99. PubMed ID: 19749146 [Abstract] [Full Text] [Related]
7. An angiotensin receptor blocker reduces the risk of congestive heart failure in elderly hypertensive patients with renal insufficiency. Nakamura T, Kanno Y, Takenaka T, Suzuki H, Efficacy of Candesartan on Outcome in Saitama Trial Group. Hypertens Res; 2005 May 30; 28(5):415-23. PubMed ID: 16156505 [Abstract] [Full Text] [Related]
8. Sympathetic nerve activity in conscious renal hypertensive rats treated with an angiotensin converting enzyme inhibitor or an angiotensin II antagonist. Niederberger M, Aubert JF, Nussberger J, Brunner HR, Waeber B. J Hypertens; 1995 Apr 30; 13(4):439-45. PubMed ID: 7629405 [Abstract] [Full Text] [Related]
9. Additive effects of spironolactone and candesartan on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure. Kasama S, Toyama T, Sumino H, Matsumoto N, Sato Y, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, Kurabayashi M. J Nucl Med; 2007 Dec 30; 48(12):1993-2000. PubMed ID: 18006623 [Abstract] [Full Text] [Related]
10. Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury. Ishiguro K, Sasamura H, Sakamaki Y, Itoh H, Saruta T. Hypertens Res; 2007 Jan 30; 30(1):63-75. PubMed ID: 17460373 [Abstract] [Full Text] [Related]
11. Sympathoinhibition caused by orally administered telmisartan through inhibition of the AT₁ receptor in the rostral ventrolateral medulla of hypertensive rats. Kishi T, Hirooka Y, Sunagawa K. Hypertens Res; 2012 Sep 30; 35(9):940-6. PubMed ID: 22573203 [Abstract] [Full Text] [Related]
12. Angiotensin blockade prevents salt-induced injury of the renal circulation in spontaneously hypertensive rats. Susic D, Zhou X, Frohlich ED. Am J Nephrol; 2009 Sep 30; 29(6):639-45. PubMed ID: 19155618 [Abstract] [Full Text] [Related]
13. Additive effects of cilnidipine and angiotensin II receptor blocker in preventing the progression of diabetic nephropathy in diabetic spontaneously hypertensive rats. Aritomi S, Niinuma K, Ogawa T, Konda T, Nitta K. Clin Exp Nephrol; 2013 Feb 30; 17(1):41-50. PubMed ID: 23011292 [Abstract] [Full Text] [Related]
15. Chronic salt loading and cardiovascular-associated changes in experimental diabetes in rats. Maeda C, Schaan B, Oliveira E, Oliveira V, De Angelis K, Irigoyen M. Clin Exp Pharmacol Physiol; 2007 Jul 30; 34(7):574-80. PubMed ID: 17581211 [Abstract] [Full Text] [Related]
16. Upregulation of the brain renin-angiotensin system in rats with chronic renal failure. Nishimura M, Takahashi H, Yoshimura M. Acta Physiol (Oxf); 2007 Apr 30; 189(4):369-77. PubMed ID: 17367405 [Abstract] [Full Text] [Related]
17. Angiotensin II type 1 receptor blocker attenuates myocardial remodeling and preserves diastolic function in diabetic heart. Tsutsui H, Matsushima S, Kinugawa S, Ide T, Inoue N, Ohta Y, Yokota T, Hamaguchi S, Sunagawa K. Hypertens Res; 2007 May 30; 30(5):439-49. PubMed ID: 17587756 [Abstract] [Full Text] [Related]
18. Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension. Yu Y, Fukuda N, Yao EH, Matsumoto T, Kobayashi N, Suzuki R, Tahira Y, Ueno T, Matsumoto K. Am J Hypertens; 2008 Jan 30; 21(1):72-7. PubMed ID: 18091747 [Abstract] [Full Text] [Related]
20. Angiotensin II receptor blocker provides pancreatic beta-cell protection independent of blood pressure lowering in diabetic db/db mice. Shao JQ, Iwashita N, Du H, Wang YT, Wang YY, Zhao M, Wang J, Watada H, Kawamori R. Acta Pharmacol Sin; 2007 Feb 30; 28(2):246-57. PubMed ID: 17241528 [Abstract] [Full Text] [Related] Page: [Next] [New Search]